You are viewing a free limited preview of Vidara Therapeutics International Limited
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access

Vidara Therapeutics International Limited

Private Company Ticker Symbol™: (VIDTHEP)

Business Summary

Vidara Therapeutics International Limited is a privately-held company that operates in the following industries: Drug-Related Products and Active Pharmaceutical Ingredients (Apis). Vidara Therapeutics International Limited headquarters are located in Ireland.

Overview & Corporate Organization

Basic Information

Fiscal Year End:12/31
Country:Ireland

Industry Information

Industry Codes

PICS™:700801™, 700805
NAICS:View
SIC:View

The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.

Mergers & Acquisitions

PrivCo's M&A Activity table for Vidara Therapeutics International Limited displays the mergers and acquisitions involving Vidara Therapeutics International Limited, for example if Vidara Therapeutics International Limited acquired or was acquired by another entity, any leveraged buyout (LBO), etc.
All data before 2006 is completely free to view! To access data from 2006 onward:
Get Full Access To This Report Now! $99 Single Company Access
 
or Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
DateStatusTargetBuyerDeal TypePrice
DetailsMay. 2012CompletedView1ViewDivestiture
Intellectual Property Sale (IP)
View
Notes
1Actimmune is a synthesized version...Read More →
Full-length notes are available with Single Report Access or PrivCo Premium Subscription.

Missing a deal? Tell us about it! tips@privco.com


You are viewing a free limited preview of Vidara Therapeutics International Limited
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access